<?xml version="1.0" encoding="UTF-8"?>
<p>The effect of age, although important, also could not be assessed as age‐stratified prevalence measures were not available for most countries. When available, these varied in how they were reported; different studies used different age group definitions, rendering a pooled analysis difficult. Another challenge was the variability in the affected age cohorts in one country to another given epidemic history, say in Egypt versus Pakistan.
 <xref rid="hep41310-bib-0011" ref-type="ref">11</xref>, 
 <xref rid="hep41310-bib-0013" ref-type="ref">13</xref>, 
 <xref rid="hep41310-bib-0050" ref-type="ref">50</xref> Inclusion of age, thus, is best addressed through in‐depth country‐specific analyses, with the development of sensitive and specific risk scores being an additional aim.
</p>
